HRP20040913A2 - Non-steroidal progesterone receptor modulators - Google Patents

Non-steroidal progesterone receptor modulators

Info

Publication number
HRP20040913A2
HRP20040913A2 HR20040913A HRP20040913A HRP20040913A2 HR P20040913 A2 HRP20040913 A2 HR P20040913A2 HR 20040913 A HR20040913 A HR 20040913A HR P20040913 A HRP20040913 A HR P20040913A HR P20040913 A2 HRP20040913 A2 HR P20040913A2
Authority
HR
Croatia
Prior art keywords
receptor modulators
progesterone receptor
steroidal progesterone
steroidal
modulators
Prior art date
Application number
HR20040913A
Other languages
English (en)
Inventor
Harold Han Hermkens Pedro
Lucas Hans
Peter Marie Antoinus Dols Paul
Bernardus Maria Rewinkel Johannes
Johanna Bernita Folmer Brigitte
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of HRP20040913A2 publication Critical patent/HRP20040913A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20040913A 2002-04-04 2003-04-01 Non-steroidal progesterone receptor modulators HRP20040913A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02076350 2002-04-04
PCT/EP2003/050085 WO2003084963A1 (fr) 2002-04-04 2003-04-01 Modulateurs de recepteur de progesterone non steroides

Publications (1)

Publication Number Publication Date
HRP20040913A2 true HRP20040913A2 (en) 2005-08-31

Family

ID=28685924

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040913A HRP20040913A2 (en) 2002-04-04 2003-04-01 Non-steroidal progesterone receptor modulators

Country Status (29)

Country Link
US (1) US7737136B2 (fr)
EP (1) EP1495030B1 (fr)
JP (1) JP4418683B2 (fr)
KR (1) KR100965173B1 (fr)
CN (1) CN1279044C (fr)
AR (1) AR039251A1 (fr)
AT (1) ATE404567T1 (fr)
AU (1) AU2003224161B2 (fr)
BR (1) BR0308890A (fr)
CA (1) CA2480940C (fr)
CY (1) CY1108495T1 (fr)
DE (1) DE60322867D1 (fr)
DK (1) DK1495030T3 (fr)
EC (1) ECSP045334A (fr)
ES (1) ES2310654T3 (fr)
HR (1) HRP20040913A2 (fr)
IL (2) IL164169A0 (fr)
IS (1) IS7452A (fr)
MX (1) MXPA04009709A (fr)
NO (1) NO20044473L (fr)
NZ (1) NZ535546A (fr)
PE (1) PE20040350A1 (fr)
PL (1) PL372846A1 (fr)
PT (1) PT1495030E (fr)
RU (1) RU2309155C2 (fr)
SI (1) SI1495030T1 (fr)
TW (1) TWI297685B (fr)
WO (1) WO2003084963A1 (fr)
ZA (1) ZA200407667B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI297685B (en) 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators
TWI370129B (en) * 2005-02-14 2012-08-11 Msd Oss Bv Non steroidal glucocorticoid receptor modulators
TWI375676B (en) * 2005-08-29 2012-11-01 Msd Oss Bv Non-steroidal glucocorticoid receptor modulators
HRP20100526T1 (hr) * 2006-09-27 2010-11-30 N.V. Organon Piridooksazepinski modulatori progesteronskog receptora
US7989442B2 (en) 2006-09-27 2011-08-02 N.V. Organon Progesterone receptor modulators
TW200914029A (en) * 2007-05-07 2009-04-01 Organon Nv New progesterone receptor modulators
US8063037B2 (en) 2007-05-07 2011-11-22 N. V. Organon Progesterone receptor modulators

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7305811A (fr) 1973-04-26 1974-10-29
US4054572A (en) * 1973-04-26 1977-10-18 Akzona Incorporated Hexahydro pyridine [1,2d] dibenza [b,f] (1,4)-diazepines
US4016161A (en) * 1974-04-24 1977-04-05 Akzona Incorporated Amino-substituted 1,2,3,4,10,146-hexahydro-pyridino[1,2-a]dibenzo[c,f]azepines
IT1207417B (it) * 1982-03-15 1989-05-17 Menarini Sas Azepina-6-one ad attivita'composti triciclici derivati dalla farmacologica, e procedimenti di 5,6-diidro-11h-dibenzo (b,e)fabbricazione relativi
DE19975054I2 (de) 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
CA2026856A1 (fr) 1989-10-05 1991-04-06 Mark G. Bock Derives de substitution en 3 de 1,4-benzodiazepines, utiles comme oxytocine
US5688808A (en) 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
IL123813A0 (en) 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
TWI297685B (en) 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators
TWI370129B (en) 2005-02-14 2012-08-11 Msd Oss Bv Non steroidal glucocorticoid receptor modulators
HRP20100526T1 (hr) 2006-09-27 2010-11-30 N.V. Organon Piridooksazepinski modulatori progesteronskog receptora

Also Published As

Publication number Publication date
RU2309155C2 (ru) 2007-10-27
AR039251A1 (es) 2005-02-16
IL164169A0 (en) 2005-12-18
KR100965173B1 (ko) 2010-06-24
DK1495030T3 (da) 2008-11-24
NZ535546A (en) 2007-01-26
JP2005528382A (ja) 2005-09-22
DE60322867D1 (de) 2008-09-25
KR20040099396A (ko) 2004-11-26
MXPA04009709A (es) 2004-12-13
ATE404567T1 (de) 2008-08-15
HK1070362A1 (en) 2005-06-17
WO2003084963A1 (fr) 2003-10-16
EP1495030A1 (fr) 2005-01-12
PE20040350A1 (es) 2004-06-17
PT1495030E (pt) 2008-11-21
SI1495030T1 (sl) 2009-02-28
PL372846A1 (en) 2005-08-08
CA2480940A1 (fr) 2003-10-16
IL164169A (en) 2010-11-30
ECSP045334A (es) 2004-11-26
CA2480940C (fr) 2011-02-08
CY1108495T1 (el) 2014-04-09
CN1649879A (zh) 2005-08-03
EP1495030B1 (fr) 2008-08-13
JP4418683B2 (ja) 2010-02-17
AU2003224161B2 (en) 2009-02-26
TW200307675A (en) 2003-12-16
ZA200407667B (en) 2006-07-26
BR0308890A (pt) 2005-01-11
ES2310654T3 (es) 2009-01-16
CN1279044C (zh) 2006-10-11
RU2004132215A (ru) 2005-04-20
TWI297685B (en) 2008-06-11
US20050171087A1 (en) 2005-08-04
AU2003224161A1 (en) 2003-10-20
NO20044473L (no) 2004-10-29
IS7452A (is) 2004-09-16
US7737136B2 (en) 2010-06-15

Similar Documents

Publication Publication Date Title
AU2003290778A8 (en) Non-steroidal farnesoid x receptor modulators
TWI340738B (en) Modulators of the glucocorticoid receptor
DE60327767D1 (de) Tricyclische steroidhormonkernrezeptor-modulatoren
GB0400440D0 (en) Receptor modulators
PL374215A1 (en) Selective estrogen receptor modulators
ZA200704223B (en) Estrogen receptor modulators
IL182829A0 (en) Estrogen receptor modulators
AU2003245773A1 (en) Vanilloid receptor modulators
GB0201203D0 (en) Modulators
IL159594A0 (en) Adenosine a3 receptor modulators
PL375559A1 (en) Calcium receptor modulating agents
AU2003237492A1 (en) Urotensin ii receptor modulators
AU2003236661A1 (en) Tensing device
ZA200510304B (en) Cannabinoid receptor modulator
AU2002335075A1 (en) Estrogen receptor modulators
IL166069A0 (en) CCK-1 receptor modulators
PL373252A1 (en) Fixing device
AU2003231523A1 (en) Estrogen receptor modulators
IL164169A0 (en) Non-steroidal progesterone receptor modulators
ZA200800690B (en) Non-steroidal progesterone receptor modulators
IL172921A0 (en) Cck-1 receptor modulators
GB0215389D0 (en) Receptor
IL178010A0 (en) Progesterone receptor modulators
HK1074442A (en) Adenosine a3 receptor modulators
AUPS283002A0 (en) Receptor

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PPPP Transfer of rights

Owner name: N.V. ORGANON, NL

ODRP Renewal fee for the maintenance of a patent

Payment date: 20080320

Year of fee payment: 6

OBST Application withdrawn